Jaap Oostendorp

4.1k citations

36 papers · 3.1k indexed · 1 hit paper · h-index 20

Co-authors: Sjoerd H. van der Burg Cornelis J.M. Melief A. Rob P.M. Valentijn Jan W. Drijfhout Marij J.P. Welters Gemma G. Kenter Dorien M. A. Berends-van der Meer Gert Jan Fleuren
Topics: Immunotherapy and Immune Responses (17 papers)Cervical Cancer and HPV Research (8 papers)Cancer Immunotherapy and Biomarkers (6 papers)
Cited by: Immunology Oncology Epidemiology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Biomaterials
Partner nations: Netherlands United States Czechia

In The Last Decade

Jaap Oostendorp

36 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Jaap Oostendorp

Since Specialization

Citations

This map shows the geographic impact of Jaap Oostendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaap Oostendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaap Oostendorp more than expected).

Fields of papers citing papers by Jaap Oostendorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaap Oostendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaap Oostendorp. The network helps show where Jaap Oostendorp may publish in the future.

Co-authorship network of co-authors of Jaap Oostendorp

This figure shows the co-authorship network connecting the top 25 collaborators of Jaap Oostendorp. A scholar is included among the top collaborators of Jaap Oostendorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaap Oostendorp. Jaap Oostendorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	575. Safety and Immunogenicity of mRNA-1403, a Multivalent Norovirus mRNA Vaccine, in Healthy Adults: Interim Results of a Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial 2025 ·Open Forum Infectious Diseases ·Till Schoofs,(unknown),(unknown),Wenlin Yuan,(unknown),Tyler S. Bartholomew,Emma Levine,(unknown),A. G. Rumyantsev,Meklit Workneh,Doran L. Fink,Jaap Oostendorp	1
2	Adjuvant effect of TLR7 agonist adsorbed on aluminum hydroxide (AS37): A phase I randomized, dose escalation study of an AS37-adjuvanted meningococcal C conjugated vaccine 2019 ·Clinical Immunology ·(unknown),Jaap Oostendorp,Thomas Koernicke,(unknown),Ugo D’Oro,(unknown),Derek T. O’Hagan,Giuseppe Del Giudice,Emilio Siena,Oretta Finco,Duccio Medini	15
3	TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor 2016 ·Respiratory Research ·(unknown),Gimano D. Amatngalim,(unknown),Jaap Oostendorp,Helene Roelofs,Christian Taube,Jan Stolk,Pieter S. Hiemstra	77
4	A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema 2016 ·QJM ·Jan Stolk,(unknown),Thaís Mauad,Jaap Jan Zwaginga,Helene Roelofs,Willem E. Fibbe,Jaap Oostendorp,Ingeborg M. Bajema,Michel I.M. Versteegh,Christian Taube,Pieter S. Hiemstra	73
5	Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma 2015 ·Cancer Immunology Immunotherapy ·(unknown),Nikki M. Loof,Kees L. M. C. Franken,Christian Taube,Jaap Oostendorp,Pieter S. Hiemstra,Marij J.P. Welters,Sjoerd H. van der Burg	16
6	CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses 2014 ·Biomaterials ·Rodney Alexander Rosalia,Luis J. Cruz,Suzanne van Duikeren,Angelino T. Tromp,Ana L Silva,Wim Jiskoot,Tanja D. de Gruijl,Clemens W.G.M. Löwik,Jaap Oostendorp,Sjoerd H. van der Burg,Ferry Ossendorp	225
7	Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles 2013 ·Cancer Immunology Immunotherapy ·Rodney Alexander Rosalia,Ana L Silva,Marcel Camps,Ahmed A. Allam,Wim Jiskoot,Sjoerd H. van der Burg,Ferry Ossendorp,Jaap Oostendorp	21
8	Development of a Nose Cream Containing the Synthetic Antimicrobial Peptide P60.4Ac for Eradication of Methicillin-Resistant Staphylococcus aureus Carriage 2013 ·Journal of Pharmaceutical Sciences ·Anikó Göblyös,Kirsten J. M. Schimmel,A. Rob P.M. Valentijn,(unknown),Robert A. Cordfunke,(unknown),Jaap Oostendorp,Peter H. Nibbering,Jan W. Drijfhout,Pieter S. Hiemstra,Jan den Hartigh	15
9	Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial 2012 ·International Journal of Cancer ·Eliane C.M. Zeestraten,Frank M. Speetjens,Marij J.P. Welters,Sepideh Saadatmand,Linda F. M. Stynenbosch,Rogier Jongen,Ellen Kapiteijn,Hans Gelderblom,Hans W. Nijman,A. Rob P.M. Valentijn,Jaap Oostendorp,Lorraine M. Fathers,Jan W. Drijfhout,Cornelis J.�H. van de Velde,Peter J.K. Kuppen,Sjoerd H. van der Burg,Cornelis J.M. Melief	46
10	Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·Ana L Silva,Rodney Alexander Rosalia,(unknown),Myrra G. Carstens,Ferry Ossendorp,Jaap Oostendorp,Wim Jiskoot	88
11	A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions 2012 ·Cancer Immunology Immunotherapy ·Peggy J. de Vos van Steenwijk,Tamara H. Ramwadhdoebé,Margriet J. Löwik,Caroline E. van der Minne,Dorien M. A. Berends-van der Meer,Lorraine M. Fathers,A. Rob P.M. Valentijn,Jaap Oostendorp,Gert Jan Fleuren,Bart W.J. Hellebrekers,Marij J.P. Welters,(unknown),Cornelis J.M. Melief,Gemma G. Kenter,Sjoerd H. van der Burg	76
12	Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study 2011 ·International Journal of Cancer ·Renee Vermeij,Ninke Leffers,Baukje‐Nynke Hoogeboom,(unknown),Rinze Wolf,Anna K.L. Reyners,Barbara H. W. Molmans,Harry Hollema,Joost Bart,Jan W. Drijfhout,Jaap Oostendorp,Ate G.J. van der Zee,Cornelis J.M. Melief,Sjoerd H. van der Burg,Toos Daemen,Hans W. Nijman	72
13	Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasiabreakdown → 2009 ·New England Journal of Medicine ·Gemma G. Kenter,Marij J.P. Welters,A. Rob P.M. Valentijn,Margriet J. Löwik,Dorien M. A. Berends-van der Meer,Annelies P.G. Vloon,(unknown),Lorraine M. Fathers,Rienk Offringa,Jan W. Drijfhout,Amon R. Wafelman,Jaap Oostendorp,Gert Jan Fleuren,Sjoerd H. van der Burg,Cornelis J.M. Melief	803
14	Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial 2009 ·International Journal of Cancer ·Ninke Leffers,Annechien J.A. Lambeck,Marloes J.M. Gooden,Baukje‐Nynke Hoogeboom,Rinze Wolf,(unknown),Bouke G. Hepkema,Pax H.B. Willemse,Barbara H. W. Molmans,Harry Hollema,Jan W. Drijfhout,Willem Sluiter,A. Rob P.M. Valentijn,(unknown),Jaap Oostendorp,Ate G.J. van der Zee,Cornelis J.M. Melief,Sjoerd H. van der Burg,Toos Daemen,Hans W. Nijman	109
15	Differential Desensitization of Homozygous Haplotypes of the β2-Adrenergic Receptor in Lymphocytes 2005 ·American Journal of Respiratory and Critical Care Medicine ·Jaap Oostendorp,Dirkje S. Postma,Haukeline H. Volders,Hajo Jongepier,Henk F. Kauffman,H. Marike Boezen,Deborah A. Meyers,Eugene R. Bleecker,S.Adriaan Nelemans,Johan Zaagsma,Herman Meurs	24
16	Exposure to TARC alters β₂-adrenergic receptor signaling in human peripheral blood T lymphocytes 2005 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Irene H. Heijink,Edo Vellenga,Jaap Oostendorp,Jan G.R. de Monchy,Dirkje S. Postma,Henk F. Kauffman	16
17	Modulation of β2- and β3-adrenoceptor-mediated relaxation of rat oesophagus smooth muscle by protein kinase C 2004 ·European Journal of Pharmacology ·Jaap Oostendorp,(unknown),Aart Terpstra,S.Adriaan Nelemans,Johan Zaagsma	12
18	Cloning, pharmacological characterization, and polymorphism screening of the guinea pig β2-adrenoceptor 2002 ·European Journal of Pharmacology ·Jaap Oostendorp,Herman Meurs,S.Adriaan Nelemans,Johan Zaagsma,Henk F. Kauffman,Dirkje S. Postma,Hendrikus Boddeke,Knut Biber	9
19	Contribution of β‐adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and β₃‐adrenoceptor knockout mice 2000 ·British Journal of Pharmacology ·Jaap Oostendorp,Frédéric Preitner,James D. Moffatt,M. Ángeles Jiménez,(unknown),Peter Molenaar,Alberto J. Kaumann	17
20	Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses. 1993 ·Environmental Health Perspectives ·Chris T. Evelo,Jaap Oostendorp,W.F. ten Berge,Paul J. A. Borm	18

About Jaap Oostendorp

Jaap Oostendorp is a scholar working on Immunology, Microbiology and Oncology, having authored 36 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Cervical Cancer and HPV Research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (2.2k citations), Oncology (1.2k citations) and Epidemiology (732 citations). Jaap Oostendorp has collaborated with scholars based in Netherlands, United States and Czechia. Frequent co-authors include Sjoerd H. van der Burg, Cornelis J.M. Melief, A. Rob P.M. Valentijn, Jan W. Drijfhout, Marij J.P. Welters, Gemma G. Kenter, Dorien M. A. Berends-van der Meer, Gert Jan Fleuren, Annelies P.G. Vloon and Rienk Offringa. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact